Retail-company Subhiksha has said that a bench of the Bombay high court set aside all the orders of the Maharashtra Food and Drug Administration (FDA) regarding the company’s warehouse at Bhiwandi and three of its vendors located there.
In August this year, FDA had passed orders of cancellation of license against three of Subhiksha’s vendors and a 20 day suspension order on Subhiksha itself.
Welcoming the judgement, R Subramaniam, MD, Subhiksha, said, “Our stance that there was nothing wrong with its warehouse operations or the hygiene of the products sold by it and that justice would be done by the high court has been vindicated by these orders of the high court. We remains committed, as always, to providing only the best quality products at the lowest prices.”
The orders of FDA were originally stayed by the high court on August 15 and subsequent to the hearings the court set aside the FDA orders against all four companies as bad in law.
Further in respect of Subhiksha, the court ordered that the commissioner FDA should re-decide the matter in accordance with law.
Subhiksha, India’s leading retail chain with 1,450 stores in over 100 cities currently operates four business verticals: supermarket (groceries), fruits and vegetables, pharmaceuticals and telecom. The Chennai-based company also plans to enter the consumer durables retailing arena with over 2 million square feet over the next year.
